BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9719608)

  • 1. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
    McMurry TJ; Pippin CG; Wu C; Deal KA; Brechbiel MW; Mirzadeh S; Gansow OA
    J Med Chem; 1998 Aug; 41(18):3546-9. PubMed ID: 9719608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics.
    Gilpin IMF; Ullrich M; Wünsche T; Zarschler K; Lebeda O; Pietzsch J; Pietzsch HJ; Walther M
    ChemMedChem; 2021 Sep; 16(17):2645-2649. PubMed ID: 33949125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the relative contribution of volume and concentration changes in Yttrium-90 labelled resin microspheres on ionization chamber measurements.
    Forwood N; Willowson KP; Tapner M; Bailey DL
    Australas Phys Eng Sci Med; 2017 Dec; 40(4):943-948. PubMed ID: 29149442
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Price TW; Renard I; Prior TJ; Kubíček V; Benoit DM; Archibald SJ; Seymour AM; Hermann P; Stasiuk GJ
    Inorg Chem; 2022 Oct; 61(43):17059-17067. PubMed ID: 36251390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.
    Holik HA; Ibrahim FM; Elaine AA; Putra BD; Achmad A; Kartamihardja AHS
    Molecules; 2022 May; 27(10):. PubMed ID: 35630536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.
    Wallnöfer EA; Thurner GC; Kremser C; Talasz H; Stollenwerk MM; Helbok A; Klammsteiner N; Albrecht-Schgoer K; Dietrich H; Jaschke W; Debbage P
    Histochem Cell Biol; 2021 Jan; 155(1):19-73. PubMed ID: 33040183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordination chemistry of [Y(pypa)]
    Li L; de Guadalupe Jaraquemada-Peláez M; Aluicio-Sarduy E; Wang X; Barnhart TE; Cai W; Radchenko V; Schaffer P; Engle JW; Orvig C
    Dalton Trans; 2020 May; 49(17):5547-5562. PubMed ID: 32270167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents.
    Clough TJ; Jiang L; Wong KL; Long NJ
    Nat Commun; 2019 Mar; 10(1):1420. PubMed ID: 30926784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of aziridinium ring opening for preparation of optically active diamine and triamine analogues: Highly efficient synthesis and evaluation of DTPA-based MRI contrast enhancement agents.
    Sun X; Chen Y; Wu N; Kang CS; Song HA; Jin S; Fu Y; Bryant H; Frank JA; Chong HS
    RSC Adv; 2015 Jan; 5(115):94571-94581. PubMed ID: 26989478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.
    Carroll V; Demoin DW; Hoffman TJ; Jurisson SS
    Radiochim Acta; 2012 Aug; 100(8-9):653-667. PubMed ID: 25382874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy.
    Sihver W; Pietzsch J; Krause M; Baumann M; Steinbach J; Pietzsch HJ
    Pharmaceuticals (Basel); 2014 Mar; 7(3):311-38. PubMed ID: 24603603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeling strategies for tumor-targeting proteinaceous drugs.
    Sugiura G; Kühn H; Sauter M; Haberkorn U; Mier W
    Molecules; 2014 Feb; 19(2):2135-65. PubMed ID: 24552984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.
    Lozza C; Navarro-Teulon I; Pèlegrin A; Pouget JP; Vivès E
    Front Oncol; 2013 Sep; 3():247. PubMed ID: 24093086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gd(CyPic3A)(H2O)2]-: a stable, bis(aquated) and high-relaxivity Gd(III) complex.
    Gale EM; Kenton N; Caravan P
    Chem Commun (Camb); 2013 Sep; 49(73):8060-2. PubMed ID: 23903523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the preparation of bifunctional gadolinium(III) chelators.
    Frullano L; Caravan P
    Curr Org Synth; 2011 Aug; 8(4):535-565. PubMed ID: 22375102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.
    Wadas TJ; Wong EH; Weisman GR; Anderson CJ
    Chem Rev; 2010 May; 110(5):2858-902. PubMed ID: 20415480
    [No Abstract]   [Full Text] [Related]  

  • 17. Primer on gadolinium chemistry.
    Sherry AD; Caravan P; Lenkinski RE
    J Magn Reson Imaging; 2009 Dec; 30(6):1240-8. PubMed ID: 19938036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.
    Liu S
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1347-70. PubMed ID: 18538888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.
    Jia B; Liu Z; Shi J; Yu Z; Yang Z; Zhao H; He Z; Liu S; Wang F
    Bioconjug Chem; 2008 Jan; 19(1):201-10. PubMed ID: 18069778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles.
    Heroux KJ; Woodin KS; Tranchemontagne DJ; Widger PC; Southwick E; Wong EH; Weisman GR; Tomellini SA; Wadas TJ; Anderson CJ; Kassel S; Golen JA; Rheingold AL
    Dalton Trans; 2007 Jun; (21):2150-62. PubMed ID: 17514336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.